ClinicalTrials.Veeva

Menu

Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia (EagleEye3P)

U

University Hospital Schleswig-Holstein (UKSH)

Status

Enrolling

Conditions

Preeclampsia
HELLP Syndrome
Eclampsia
Kidney Disease

Study type

Observational

Funder types

Other

Identifiers

NCT07151339
D557/24

Details and patient eligibility

About

Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)

Enrollment

100 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • older than 18 yrs
  • diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy

Exclusion criteria

  • unable for informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Laura K Sievers, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems